Theradiag: over 2.8 million shares tendered to the takeover bid
In total, Biosynex holds 9,032,820 shares, representing 68.86% of the share capital and at least 68.56% of the voting rights. As the minimum shareholding requirement has been met, the offer has been successful.
Settlement and delivery of the tender offer will take place according to the timetable communicated by Euronext Paris. A subsequent publication will specify the dates and duration of the reopening of the offer.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction